IONS

Ionis Pharmaceuticals, Inc.

Halal Rating :
Comfortable
Last Price $31.44 Last updated:
Market Cap $6.97b
7D Change -10.02%
1 Year Change -38.37%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange NASDAQ
Next Earnings Date Oct. 31, 2024

Ionis Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing RNA-targeted therapeutics. The company specializes in developing medicines for patients with unmet medical needs in various therapeutic areas including neurological, cardiometabolic, and rare diseases. Their proprietary antisense technology platform is used to develop novel drugs that target RNA to treat a wide variety of diseases.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $133.81m $305.16m - $22.69m 0.00% 7.44%
June 30, 2024 $225.25m $314.13m - $22.79m 0.00% 7.25%
March 31, 2024 $119.5m $291.12m - $22.11m 0.00% 7.59%

Company Impact

Help us evaluate Ionis Pharmaceuticals, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates